Global Portable Oxygen Concentrators Market By Type (Molecular Sieve Oxygen Concentrator, Macromolecule Oxygen Permeable Membrane Oxygen Concentrator, Electrolysis Oxygen Concentrator, Chemical Oxygen Concentrator, Others) By Deliver System (Continuous Flow, Pulse Flow) By Application (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Respiratory Distress Syndrome, Sleep Apnea, Others) By End-User (Hospitals, Homecare Settings, Ambulatory Surgical Centers, Others) By Sales Channel (Direct Sales, Distributors) By Region, Competition Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.79 Billion
CAGR (2026-2031)	9.85%
Fastest Growing Segment	Molecular Sieve Oxygen Concentrator
Largest Market	North America
Market Size (2031)	USD 6.66 Billion

Market Overview

The Global Portable Oxygen Concentrators Market will grow from USD 3.79 Billion in 2025 to USD 6.66 Billion by 2031 at a 9.85% CAGR. Portable oxygen concentrators are medical devices that filter nitrogen from ambient air to deliver oxygen-enriched gas to patients, facilitating mobility and independence for those requiring respiratory therapy. The primary drivers fueling market growth include the rapidly aging global population and the increasing preference for home-based care settings over prolonged hospital stays. Furthermore, the rising incidence of respiratory conditions creates a sustained demand for long-term oxygen therapy solutions. According to the International Pharmaceutical Federation, in 2024, chronic obstructive pulmonary disease was estimated to affect 391 million people globally, highlighting the substantial and expanding patient base necessitating effective respiratory support.

However, a significant challenge impeding broader market expansion is the high acquisition cost associated with these mobile devices compared to traditional stationary tanks. Inconsistent reimbursement policies and limited public insurance coverage, particularly in developing nations, often force patients to opt for less expensive delivery methods, thereby restricting the adoption of portable units in cost-sensitive regions.

Key Market Drivers

Escalating exposure to environmental pollutants and tobacco smoke is a primary catalyst propelling the Global Portable Oxygen Concentrators Market. Deteriorating air quality directly exacerbates the prevalence of chronic respiratory conditions, creating a critical need for mobile therapeutic devices that allow patients to manage symptoms amidst adverse environmental factors. According to the American Lung Association, April 2024, in the 'State of the Air 2024' report, more than 131.2 million people in the United States lived in counties with unhealthy levels of ozone or particle pollution, representing a significant demographic susceptible to long-term respiratory distress. This environmental burden forces a shift from stationary care to portable solutions, ensuring continuous oxygen delivery for active patients while mitigating the impact of poor air quality on compromised respiratory systems.

Simultaneously, technological advancements in device miniaturization and battery efficiency are reshaping the market by overcoming historical mobility barriers. Manufacturers are increasingly launching smart, lightweight units that integrate remote monitoring, thereby enhancing patient independence and treatment adherence. According to Belluscura PLC, November 2024, in the 'Belluscura wholly owned subsidiary enters into $4 Million Credit Facility' announcement, the company secured $4 million to support the formal launch of the DISCOV-R portable oxygen concentrator, driven by increasing consumer demand. This surge in innovation is underpinned by substantial economic activity within the sector; according to Inogen, Inc., in 2024, the company reported a total revenue of $315.7 million for the fiscal year 2023, highlighting the enduring commercial viability and scale of the portable respiratory care market.

Download Free Sample Report

Key Market Challenges

The high acquisition cost of portable oxygen concentrators constitutes a significant restraint on market growth, particularly when weighed against the affordability of traditional stationary tanks. Although portable units offer patients the benefit of mobility, the financial burden associated with purchasing or renting these devices prevents widespread adoption. This economic barrier is further compounded by restrictive reimbursement policies and insufficient insurance coverage, which often fail to account for the higher costs of mobile technology compared to standard delivery methods. Consequently, many patients, especially those in cost-sensitive regions, are forced to rely on less expensive, stationary alternatives, thereby stifling the demand for portable solutions.

According to the American Association for Homecare, in 2024, Medicare reimbursement rates for key home medical equipment categories in non-rural areas experienced reductions averaging 20.1 percent. This substantial decrease in financial support discourages providers from supplying higher-cost devices like portable concentrators, as the reimbursement levels often do not cover the operational expenses involved. As a result, the market faces reduced penetration rates, with economic pressures effectively limiting the availability of these mobility-enhancing devices to a smaller segment of the patient population.

Key Market Trends

The Rising Market Preference for High-Efficiency Pulse Dose Technology is fundamentally reshaping the sector as patients increasingly prioritize mobility and lightweight form factors over traditional continuous flow options. This delivery mechanism, which intelligently synchronizes oxygen release with the user's inhalation, allows for significantly smaller device architectures compared to continuous flow counterparts, directly addressing the growing demand for active lifestyle support. This shift towards more compact, efficient therapeutic solutions is substantiated by recent commercial performance; according to Inogen, Inc., August 2025, in the 'Second Quarter 2025 Financial Results' press release, the company reported a 19% year-over-year increase in unit sales volumes, a surge attributed to the accelerating market conversion from heavy traditional tanks to these portable, pulse-dose enabled concentrators.

Concurrently, there is a notable Shift Towards Modular and Field-Serviceable Product Designs aimed at mitigating the high operational expenses associated with device maintenance. Manufacturers are increasingly engineering units with user-replaceable components, such as sieve columns and battery cells, which eliminates the need for costly factory returns and reduces critical device downtime for patients. This design philosophy is becoming a central value proposition for providers seeking to minimize total cost of ownership; according to Tekcapital, April 2025, in the 'Portable Oxygen Concentrator Market Poised for Global Expansion' article, Belluscura's adoption of a modular platform for its DISCOV-R device is highlighted as a strategic innovation designed to future-proof patient care while significantly streamlining the serviceability of respiratory assets.

Segmental Insights

The molecular sieve oxygen concentrator segment represents the fastest-growing category in the global portable oxygen concentrators market, driven by advancements in pressure swing adsorption technology. These components utilize efficient zeolite materials to isolate oxygen, enabling the production of smaller and lighter devices that maintain medical-grade purity. This reduction in size directly supports patient adherence to therapy during travel and ensures compliance with portability guidelines established by the Federal Aviation Administration. As a result, the demand for high-efficiency molecular sieves continues to rise as manufacturers prioritize device miniaturization and patient mobility.

Regional Insights

North America holds a dominant position in the global portable oxygen concentrators market, primarily driven by the rising prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease. The region benefits from established healthcare infrastructure and favorable reimbursement policies provided by the Centers for Medicare & Medicaid Services, which facilitate patient access to mobile therapeutic devices. Additionally, stringent product approvals and safety standards enforced by the U.S. Food and Drug Administration foster high consumer confidence. The strong presence of major medical device manufacturers further ensures widespread availability and adoption across the region.

Recent Developments

• In October 2025, CAIRE Inc. announced that its FreeStyle Comfort portable oxygen concentrator featuring proprietary autoSAT technology was available in the United States. This technology, previously utilized in the company's transportable devices, allows the concentrator to adjust oxygen delivery automatically to maintain a consistent volume in response to the patient's breath rate during activity or rest. The introduction of this feature aimed to support a more active lifestyle for oxygen therapy users by ensuring the device adapts to their changing respiratory needs.
• In November 2024, Belluscura announced that it had secured a credit facility of up to $4 million from Sallyport Commercial Finance to support the formal launch of its DISCOV-R portable oxygen concentrator. This financing followed the company's receipt of Medicare clearance for the device in late October 2024. The funds were allocated to build out manufacturing, distribution, and sales capabilities for the DISCOV-R, which the company planned to introduce to the business-to-business market after an initial limited direct-to-consumer release.
• In October 2024, Inogen, Inc. announced the United States market release of the Rove 4 Portable Oxygen Concentrator. This new device features a fourth flow setting capable of delivering up to 840 ml/min of medical-grade oxygen while weighing less than 3 pounds. The product launch included three battery configurations, offering up to 5 hours and 45 minutes of operation, designed to provide patients with greater mobility and choice for daily activities. The company emphasized that this launch represented a significant milestone in its commitment to serving patients requiring oxygen therapy.
• In October 2024, Drive DeVilbiss Healthcare launched the PulmO2 Oxygen Concentrator, a device developed in collaboration with Sanrai International to improve oxygen access in low- and middle-income countries. This new concentrator was engineered to operate effectively in resource-limited settings, featuring energy-efficient performance, solar power compatibility, and the ability to function in high-altitude and harsh environmental conditions. The collaboration aimed to address the critical gap in healthcare for underserved regions by providing a robust and durable oxygen therapy solution that can withstand unreliable power supplies.

Key Market Players

• Inogen, Inc.
• Koninklijke Philips N.V.
• CAIRE Inc.
• Drive DeVilbiss Healthcare
• ResMed Inc.
• O2 Concepts LLC
• Precision Medical Inc.
• Nidek Medical Products Inc.
• GCE Group
• Besco Medical Co., Ltd.

By Type	By Deliver System	By Application	By End-User	By Sales Channel	By Region
Molecular Sieve Oxygen Concentrator Macromolecule Oxygen Permeable Membrane Oxygen Concentrator Electrolysis Oxygen Concentrator Chemical Oxygen Concentrator Others	Continuous Flow Pulse Flow	Chronic Obstructive Pulmonary Disease (COPD) Asthma Respiratory Distress Syndrome Sleep Apnea Others	Hospitals Homecare Settings Ambulatory Surgical Centers Others	Direct Sales Distributors	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Portable Oxygen Concentrators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Portable Oxygen Concentrators Market, By Type:

• Molecular Sieve Oxygen Concentrator
• Macromolecule Oxygen Permeable Membrane Oxygen Concentrator
• Electrolysis Oxygen Concentrator
• Chemical Oxygen Concentrator
• Others

• Portable Oxygen Concentrators Market, By Deliver System:

• Continuous Flow
• Pulse Flow

• Portable Oxygen Concentrators Market, By Application:

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Respiratory Distress Syndrome
• Sleep Apnea
• Others

• Portable Oxygen Concentrators Market, By End-User:

• Hospitals
• Homecare Settings
• Ambulatory Surgical Centers
• Others

• Portable Oxygen Concentrators Market, By Sales Channel:

• Direct Sales
• Distributors

• Portable Oxygen Concentrators Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE